Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Operating Income (2020 - 2025)

Biofrontera has reported Operating Income over the past 6 years, most recently at $4.6 million for Q4 2025.

  • Quarterly results put Operating Income at $4.6 million for Q4 2025, up 366.3% from a year ago — trailing twelve months through Dec 2025 was -$11.3 million (up 34.08% YoY), and the annual figure for FY2025 was -$11.3 million, up 34.06%.
  • Operating Income for Q4 2025 was $4.6 million at Biofrontera, up from -$6.3 million in the prior quarter.
  • Over the last five years, Operating Income for BFRIW hit a ceiling of $4.6 million in Q4 2025 and a floor of -$16.1 million in Q3 2021.
  • Median Operating Income over the past 5 years was -$4.8 million (2023), compared with a mean of -$4.7 million.
  • Biggest five-year swings in Operating Income: crashed 911.17% in 2021 and later soared 366.3% in 2025.
  • Biofrontera's Operating Income stood at -$1.9 million in 2021, then crashed by 193.58% to -$5.6 million in 2022, then surged by 30.75% to -$3.9 million in 2023, then soared by 55.71% to -$1.7 million in 2024, then soared by 366.3% to $4.6 million in 2025.
  • The last three reported values for Operating Income were $4.6 million (Q4 2025), -$6.3 million (Q3 2025), and -$5.1 million (Q2 2025) per Business Quant data.